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Brucellosis is a zoonotic infection transmitted from animals
to humans by the ingestion of infected food products, direct
contact with an infected animal, or the inhalation of aerosols.
Among these, inhalation is remarkably efficient given the
relatively low concentration of organisms (10–100 bacteria)
needed to establish infection in humans. Brucella is a facul-
tative intracellular pathogen that survives and multiplies in
phagocytes, and it has evolved to avoid the host’s immune
system. Brucellosis is usually characterized by the long-term
persistence of the bacteria in the body. The diagnosis can be
challenging since the disease can involve any body organ or
system, and its symptoms may overlap with those of a wide
spectrum of infectious, as well as non-infectious conditions.
The clinical presentations of brucellosis are not only undu-
lant fever but also joint manifestations, such as spondylitis,
and neurological complications, often associated with per-
sonality changes (anxiety, amnesia, delusions, hallucina-
tions, delirium, phobias and irritability), in addition to pro-
longed frontal or occipital headaches. Additional symptoms
are anorexia and abdominal pain.
“Micrococcus melitensis” was first isolated in 1887 by
David Bruce (1855–1931), who detected the bacterium in the
spleen of humans who had died from undulant fever in
Malta. It is believed that Florence Nightingale (1820–1910,
the famous nurse driving implement of hygiene in hospitals)
endured over 25 years of the illness, including personality
changes (neurobrucellosis) and spondylitis, which left her
bedridden for six years. The severity of this disease and the
lack of vaccines suitable for use in humans have led to the
investigation of Brucella as bioterrorism agents. Indeed, the
American military weaponized Brucella suis in 1954; how-
ever, changing global politics resulted in the abandonment of
these studies following the Biological and Toxic Weapons
Convention of 1972.
The book Brucella. Molecular microbiology and
genomics introduces the reader to what is known thus far and
to the current challenges in the taxonomy, genomics and pro-
teomics, diagnosis and epidemiology, vaccine development,
virulence mechanisms, and life cycle posed by these enig-
matic bacteria. The authors of the 13 chapters are experts in
the field and they are the book’s editors, Ignacio López-Goñi
(University of Navarra, Spain) and David O’Callaghan
(INSERM, Nimes, France).
The genus Brucella belongs to the alphaproteobacteria. In
addition to the type genus Brucella, six further genera,
Crabtreella, Daeguia, Mycoplana, Ochrobactrum, Paeno-
chrobactrum, and Pseudochrobactrum, are currently recog-
nized within the family Brucellaceae. The closest phyloge-
netic neighbor of Brucella is Ochrobactrum. Initially, two
species were described for Brucella, B. melitensis (melitensis
in Latin refers to the Malta island) and B. abortus (named
after the discovery that the organism is responsible for spon-
taneous abortion in cattle, Chapter 1). Currently, the genus
Brucella consists of ten species with validly published
names. Of these, the six so-called classical species show a
preferential host range and other distinguishing phenotypic
features: B. melitensis (infects mainly sheep and goats),
B. abortus (cattle and other bovidae), B. suis (swine), B. ovis
(sheep), B. neotomae (desert woodrats) and B. canis (dogs).
The remaining four species comprise two from marine mam-
mals, B. ceti and B. pinnipedialis, and the novel B. microti
(common voles) and B. inopinata (recently isolated from a
breast-implant infection in an elderly woman). 
In 2002, two Brucella genomes were sequenced and ana-
lyzed. At present, 40 Brucella genomes have been sequenced
(Chapter 2). The Brucella genome is composed of two chro-
mosomes. Expression analysis in Brucella grown in vitro has
confirmed a higher rate of synthesis of proteins encoded in
chromosome I than in chromosome II (Chapter 5). The pres-
ence of two chromosomes could be consistent with the abili-
ty of Brucella to adapt and live in at least two very different
environments, as free-living bacteria and intracellularly. In
the latter, the bacterium must metabolically adapt to the intra-
cellular environment and then manipulate its host cell’s biol-
ogy to create conditions for its survival and multiplication.
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Thus, the identification of protein shifts and interactions is
necessary to understand the Brucella life cycle (Chapter 6).
A major aspect of the pathogenicity of Brucella is its sur-
vival and replication within host macrophages. However, the
Brucella genome does not seem to encode the classical viru-
lence factors found in other bacterial pathogens; rather, its
main virulence factors are a lipopolysaccharide (LPS) of low
endotoxicity (Chapter 7), the BvrR/BvrS system, which con-
trols the expression of a set genes involved in a broad range
of species-specific functions (Chapter 10), and the type IV
secretion system (Chapter 11). An interesting aspect of
Brucella, albeit one thus far incompletely studied, is its gene
clusters acquired by horizontal transfer, including genomic
islands, whose acquisition and deletion may be related to the
host preference manifested by the corresponding Brucella
species (Chapter 3). The genomic islands contained in
Brucella are made up of functional classes of genes that have
been divided into two groups: one comprising virulence fac-
tors and the other, genes of metabolic or unknown function.
Moreover, virulence may also depend on metal acquisition
(Chapter 9).
Traditionally, brucellosis is diagnosed using cultural and
serological approaches. The potential of molecular assays for
Brucella identification based on 16S rRNA, the cell surface
protein bcsp31, IS711, etc., is a subject of current investiga-
tions (Chapter 4). However, such assays will need to be val-
idated in clinical samples before they can be adapted for rou-
tine laboratory testing.
Brucellosis is an important bacterial zoonosis worldwide.
In endemic areas (Mediterranean Europe, Middle East, Latin
America), the incidence of the disease in humans may be
more than 200 per 100,000 habitants. The classical treatment
of brucellosis consists of a course of antibiotics (doxycycline
and rifampicin) for six weeks. New antibacterials that are
specifically active at the intracellular phase of Brucella are
being developed. Such drugs would also have the potential to
limit the selection pressure favoring the growth of resistant
mutants, thereby reducing the secondary effects of antibiotic
treatment on the human microbiota (Chapter 12). Other
strategies aimed at the control of Brucella include a vaccine
(Chapter 13). 
Brucella. Molecular microbiology and genomics can be
recommended to microbiologists, immunologists, veterinari-
ans, and clinicians with an interest in microbial pathogenesis,
host-bacterium interactions, and microbial diagnosis.
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